FDA smoothing path for generic combo, complex drugs

FDA Commissioner Scott Gottlieb Tuesday announced new policies intended to increase generic competition, especially for drug-device combination products and for drugs that have been difficult for FDA to approve

Read the full 297 word article

User Sign In